Cancer Research and Treatment

Original Article

Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer: Jun Hwa Lee, Yun Hwan Kim, Kyung-Hee Kim, Jae Youl Cho, Sang Myung Woo, Byong Chul Yoo, Seung Cheol Kim; Cancer Res Treat. 2018;50(3):883-893. Published online September 18, 2017; DOI: https://doi.org/10.4143/crt.2017.275

Abstract PDF Supplementary Material PubReader ePub

Purpose
We sought to develop a matrix assisted laser desorption ionization-time of flight (MALDI-TOF)-based, ovarian cancer (OVC), low-mass-ion discriminant equation (LOME) and to evaluate a possible supportive role for triple-TOF mass analysis in identifying metabolic biomarkers.
Materials and Methods
A total of 114 serum samples from patients with OVC and benign ovarian tumors were subjected to MALDI-TOF analysis and a total of 137 serum samples from healthy female individuals and patients with OVC, colorectal cancer, hepatobiliary cancer, and pancreatic cancer were subjected to triple-TOF analysis. An OVC LOME was constructed by reference to the peak intensity ratios of discriminatory low-mass ion (LMI) pairs. Triple-TOF analysiswas used to select and identify metabolic biomarkers for OVC screening.
Results
Three OVC LOMEs were finally constructed using discriminatory LMI pairs (137.1690 and 84.4119 m/z; 496.5022 and 709.7642 m/z; and 524.5614 and 709.7642 m/z); all afforded accuracies of > 90%. The LMIs at 496.5022 m/z and 524.5614 m/z were those of lysophosphatidylcholine (LPC) 16:0 and LPC 18:0. Triple-TOF analysis selected seven discriminative LMIs; each LMI had a specificity > 90%. Of the seven LMIs, fourwith a 137.0455 m/z ion atretention times of 2.04-3.14 minuteswere upregulated in sera from OVC patients; the ion was identified as that derived from hypoxanthine.
Conclusion
MALDI-TOF–based OVC LOMEs combined with triple-TOF–based OVC metabolic biomarkers allow reliable OVC screening; the techniques are mutually complementary both quantitatively and qualitatively.

Citations

Citations to this article as recorded by

Detection of Protein and Metabolites in Cancer Analyses by MALDI 2000–2025
Dorota Bartusik-Aebisher, Daniel Roshan Justin Raj, David Aebisher
Cancers.2025; 17(21): 3524. CrossRef
Preliminary Metabolomics Study Suggests Favorable Metabolic Changes in the Plasma of Breast Cancer Patients after Surgery and Adjuvant Treatment
Andrea Jiménez-Franco, Juan Manuel Jiménez-Aguilar, Marta Canela-Capdevila, Raquel García-Pablo, Helena Castañé, Cristian Martínez-Navidad, Pablo Araguas, Bárbara Malavé, Rocío Benavides-Villarreal, Johana C. Acosta, Alina Iuliana Onoiu, Navita Somaiah, J
Biomedicines.2024; 12(10): 2196. CrossRef
Circulating proteins as predictive and prognostic biomarkers in breast cancer
Hugo Veyssière, Yannick Bidet, Frederique Penault-Llorca, Nina Radosevic-Robin, Xavier Durando
Clinical Proteomics.2022;[Epub] CrossRef
Applications of MALDI-MS/MS-Based Proteomics in Biomedical Research
Laura Darie-Ion, Danielle Whitham, Madhuri Jayathirtha, Yashveen Rai, Anca-Narcisa Neagu, Costel C. Darie, Brînduşa Alina Petre
Molecules.2022; 27(19): 6196. CrossRef
Methylglyoxal Adducts Levels in Blood Measured on Dried Spot by Portable Near-Infrared Spectroscopy
Giuseppe Bonapace, Francesco Gentile, Nicola Coppedé, Maria Laura Coluccio, Virginia Garo, Marco Flavio Michele Vismara, Patrizio Candeloro, Giuseppe Donato, Natalia Malara
Nanomaterials.2021; 11(9): 2432. CrossRef
Identification of New Peptide Biomarkers for Bacterial Bloodstream Infection
Yating Ma, Xinyu Wen, Yi Kong, Chen Chen, Ming Yang, Shang He, Jianan Wang, Chengbin Wang
PROTEOMICS – Clinical Applications.2020;[Epub] CrossRef
Performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in diagnosis of ovarian cancer: a systematic review and meta-analysis
Kexin Li, Yuqing Pei, Yue Wu, Yi Guo, Wei Cui
Journal of Ovarian Research.2020;[Epub] CrossRef
Comparative cerebrospinal fluid metabolites profiling in glioma patients to predict malignant transformation and leptomeningeal metastasis with a potential for preventive personalized medicine
Ji Hye Im, Byong Chul Yoo, Jun Hwa Lee, Kyung-Hee Kim, Tae Hoon Kim, Kyue-Yim Lee, Jong Heon Kim, Jong Bae Park, Ji-Woong Kwon, Sang Hoon Shin, Heon Yoo, Ho-Shin Gwak
EPMA Journal.2020; 11(3): 469. CrossRef
Exploring Serum Metabolic Markers for the Discrimination of Ccrcc From Renal Angiomyolipoma By Metabolomics
Mingfeng Xiang, Feng Du, Jing Dai, Ling Chen, Ruijin Geng, Huiming Huang, Baogang Xie
Biomarkers in Medicine.2020; 14(8): 675. CrossRef
Metabolomic Biomarkers in Gynecology: A Treasure Path or a False Path?
Igor Govorov , Stanislav Sitkin , Tatyana Pervunina , Alexey Moskvin , Denis Baranenko , Eduard Komlichenko
Current Medicinal Chemistry.2020; 27(22): 3611. CrossRef

13,509 View
253 Download
11 Web of Science
10 Crossref

First
Prev
Page of 1
Next
Last

Search